Purchase Order HHSN275201800069P

The U.S. Department of Health and Human Services (HHS) - National Institute of Diabetes and Digestive and Kidney Diseases awarded a $5,372.00 Firm Fixed Price Purchase Order to Vigene Biosciences, Inc., a minority-owned, for-profit, Asian-Pacific American-owned small business. The contract, awarded on September 4, 2015, is for laboratory and testing services, as well as specific virus-related products such as Anti-HER2 CAR-T Lentivirus Particles, Clinical Grade Virus Vectors, and Viruses:...

This purchase order awards Vector Biosystems, Inc., doing business as Vector Biolabs, $12,060 to deliver two custom adeno-associated viral constructs to the National Center for Advancing Translational Sciences within the Department of Health and Human Services' National Institutes of Health. Specifically, Vector Biosystems will provide one AAV6 vector containing GFP and an shRNA targeting human COLQ, and one AAV6 vector containing GFP and an shRNA targeting human DOK7. Both constructs are to...

Genewiz, LLC, a subsidiary of Azenta, Inc. (doing business as Brooks Life Sciences Inc.), was awarded a $17,880 firm fixed-price purchase order on May 28, 2020, for Illumina sequencing services. This total small business set-aside contract, posted on April 9, 2020, with a due date of May 5, 2020, will be performed at Genewiz's facility in South Plainfield, New Jersey, with completion targeted for September 30, 2020. The contract was funded by a civilian federal agency within the Midwest Area....

The U.S. government awarded a $2,656 firm fixed-price purchase order to Genscript USA Inc. for molecular biology services on July 28, 2018, with an ultimate completion date of August 15, 2018. The contract, issued by the Pacific West Area civilian agency, calls for the synthesis of a CAMV 35S promoter followed by a CTV-RB115 sequence consisting of 5,711 base pairs and the cloning of this sequence in pBluescript II SK(+) vector. The work will be performed at Genscript's facility in Piscataway,...

NUGEN TECHNOLOGIES, INC. received a $7,219.20 firm fixed-price Blanket Purchase Agreement (BPA) call from the National Institute of Environmental Health Sciences on August 16, 2016, with completion targeted for March 31, 2017. The award was issued to Tecan Genomics, Inc., a Switzerland-based manufacturer of life science laboratory automation and detection solutions specializing in genomic research technologies. The work will be performed in San Carlos, California. This contract was not subject...

This firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Synbio Technologies LLC, a small business located in Monmouth Junction, New Jersey. The $11,994.20 contract is for the delivery of a synthetic plasmid containing the AP50c phage genome, modified to include an eGFP tag. The requirement was originally posted as a special notice by the U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the U.S. Army Medical Research Institute of Infectious...

Verogen, Inc. was awarded a firm fixed price contract by the Defense Health Agency to provide 60 units of the MiSeq Reagent Kit V3 for $144,477.43. This is a BPA call order against Verogen's $7.43 million single-award blanket purchase agreement with the agency, which facilitates the procurement of standardized laboratory supplies to support the agency's genomic sequencing programs. The contract has a completion date of January 2, 2024 and was awarded on November 16, 2023. Verogen is a...

This firm fixed-price purchase order was awarded to Novogene Corporation Inc., a minority-owned small business, by the National Institute of Child Health and Human Development for gene expression profiles (Alirocumab neuroinflammation apoptosis) in the amount of $54,080.00. The award is not associated with a set-aside and is based on a competitive solicitation for providing and analyzing gene expression and complete DNA library preparation, NovaSeq PSK9 (sequencing), and customized analysis....

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $345,333 firm fixed price purchase order to Genewiz, LLC for whole genome sequencing services using 90 human induced pluripotent stem cell samples. The solicitation sought these sequencing services to be performed within 45 days of sample receipt in September 2020. Genewiz will conduct the work at its facility in South Plainfield, New Jersey as the incumbent...

Vizgen Inc. was awarded a firm fixed price purchase order contract valued at $24,500 by the National Institutes of Health's National Center for Advancing Translational Sciences to conduct a proof of principle study utilizing a custom gene panel of up to 140 genes. The work will be performed in Potomac, Maryland through February 2025. No set aside designation was used for this award to the for-profit manufacturer of spatial genomics tools. The National Center for Advancing Translational...